Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica
· Delayed Price · Currency is JMD 2.880
+0.010 (0.35%)
At close: Dec 5, 2025
Indies Pharma Jamaica Ratios and Metrics
Market cap in millions JMD. Fiscal year is November - October.
Millions JMD. Fiscal year is Nov - Oct.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2019 - 2016 |
| Market Capitalization | 3,838 | 4,224 | 4,184 | 4,184 | 4,531 | 3,598 | Upgrade
|
| Market Cap Growth | 8.68% | 0.95% | - | -7.65% | 25.93% | -12.90% | Upgrade
|
| Enterprise Value | 4,465 | 4,904 | 4,839 | 4,918 | 5,265 | 3,950 | Upgrade
|
| Last Close Price | 2.88 | 3.04 | 2.89 | 2.79 | 2.91 | 2.23 | Upgrade
|
| PE Ratio | 15.75 | 16.78 | 19.23 | 18.95 | 26.99 | 17.35 | Upgrade
|
| PS Ratio | 3.34 | 3.65 | 3.96 | 4.46 | 5.35 | 4.70 | Upgrade
|
| PB Ratio | 2.23 | 3.27 | 3.43 | 3.62 | 4.17 | 5.02 | Upgrade
|
| P/TBV Ratio | 3.14 | 5.08 | 5.38 | 5.38 | 5.89 | 5.98 | Upgrade
|
| P/FCF Ratio | 11.13 | 17.52 | 15.76 | 14.49 | 13.91 | - | Upgrade
|
| P/OCF Ratio | 9.84 | 16.90 | 14.97 | 13.27 | 12.36 | - | Upgrade
|
| EV/Sales Ratio | 3.89 | 4.23 | 4.59 | 5.25 | 6.22 | 5.16 | Upgrade
|
| EV/EBITDA Ratio | 13.20 | 16.17 | 16.74 | 16.34 | 22.55 | 17.29 | Upgrade
|
| EV/EBIT Ratio | 16.24 | 17.32 | 17.91 | 17.46 | 24.22 | 18.19 | Upgrade
|
| EV/FCF Ratio | 12.96 | 20.34 | 18.23 | 17.02 | 16.16 | - | Upgrade
|
| Debt / Equity Ratio | 0.49 | 0.66 | 0.74 | 0.71 | 0.79 | 1.24 | Upgrade
|
| Debt / EBITDA Ratio | 2.49 | 2.48 | 2.73 | 2.41 | 3.15 | 3.34 | Upgrade
|
| Debt / FCF Ratio | 2.44 | 3.55 | 3.40 | 2.82 | 2.63 | - | Upgrade
|
| Asset Turnover | 0.46 | 0.51 | 0.49 | 0.46 | 0.46 | 0.62 | Upgrade
|
| Inventory Turnover | 1.83 | 2.22 | 2.41 | 1.63 | 1.79 | 1.68 | Upgrade
|
| Quick Ratio | 0.42 | 0.45 | 2.92 | 5.70 | 3.19 | 3.95 | Upgrade
|
| Current Ratio | 0.73 | 0.85 | 5.07 | 10.24 | 5.84 | 6.22 | Upgrade
|
| Return on Equity (ROE) | 16.49% | 20.04% | 18.32% | 19.68% | 18.62% | 29.37% | Upgrade
|
| Return on Assets (ROA) | 6.86% | 7.78% | 7.88% | 8.62% | 7.30% | 11.04% | Upgrade
|
| Return on Capital (ROIC) | 7.35% | 8.29% | 8.25% | 9.00% | 7.66% | 11.76% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.90% | 20.60% | 12.90% | 14.20% | 11.20% | 13.90% | Upgrade
|
| Earnings Yield | 6.37% | 5.96% | 5.20% | 5.28% | 3.71% | 5.76% | Upgrade
|
| FCF Yield | 8.98% | 5.71% | 6.34% | 6.90% | 7.19% | -3.04% | Upgrade
|
| Dividend Yield | 3.83% | 3.62% | 3.81% | 4.05% | 3.78% | 6.27% | Upgrade
|
| Payout Ratio | 73.56% | 58.22% | 69.37% | 68.20% | 87.32% | 89.97% | Upgrade
|
| Buyback Yield / Dilution | -0.41% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 3.45% | 3.62% | 3.81% | 4.05% | 3.78% | 6.27% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.